Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-13

Clinical Trial Update: Efficacy and Safety of a Combined Serum Containing Melasyl™, 10% Niacinamide, Hyaluronic Acid, and HEPES [NA]

View source ↗

Summary

Clinical trial update for a topical serum containing Melasyl, 10% Niacinamide, Hyaluronic Acid, and HEPES for melasma and post-inflammatory hyperpigmentation. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Melasyl-containing topical serum

Snippet

Sponsor: Dr.dr.Irma Bernadette, SpKK (K) | Conditions: Melasma, Post-acne Hyperpigmentation | NA | Status: NOT_YET_RECRUITING